NCT04033471

Brief Summary

this study aim to Compare the effect of preoperative Epidural Midazolam, Morphine and their combination in postoperative pain relief and total morphine consumption.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

July 24, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 26, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

February 24, 2021

Status Verified

February 1, 2021

Enrollment Period

1.7 years

First QC Date

July 24, 2019

Last Update Submit

February 23, 2021

Conditions

Keywords

epidural, morphine, midazolam, acute postoperative pain

Outcome Measures

Primary Outcomes (1)

  • time to first request of analgesia

    the time between the end of operation and tracheal extubation to the first request for supplemental analgesics and its administration to the patient

    1st 48 hours postoperative

Secondary Outcomes (1)

  • the cumulative consumption of morphine in the 1st 48h postoperatively

    1st 48 hours postoperative

Study Arms (3)

MI

ACTIVE COMPARATOR

Bupivacaine 0.25% + midazolam 5mg in total volume 10m1

Drug: midazolam

MM

ACTIVE COMPARATOR

Bupivacaine 0.25% + midazolam 5mg and morphine 5mg in total volume 10ml

Drug: midazolam

MO

ACTIVE COMPARATOR

bupivacaine 0.25% + morphine 5 mg in total volume 10 ml

Drug: midazolam

Interventions

epidural needle in the L1-2 or L2-3 space , and using loss of resistance technique udder strict aseptic condition 10 ml of the prepared drug will be given

Also known as: morphine, bupivacaine
MIMMMO

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-II patients scheduled for major abdominal cancer surgeries

You may not qualify if:

  • patients with known allergy to the study drugs,
  • significant cardiac, respiratory, renal or hepatic disease,
  • drug or alcohol abuse,
  • psychiatric illness that would interfere with perception and assessment of pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, 171516, Egypt

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Interventions

MidazolamMorphineBupivacaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

BenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Central Study Contacts

Shereen M Kamal, Associate proferssor

CONTACT

Khaled M Fares, proferssor

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: epidural bupiviacain
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor of anesthesia, ICU and pain manegement

Study Record Dates

First Submitted

July 24, 2019

First Posted

July 26, 2019

Study Start

July 1, 2019

Primary Completion

March 1, 2021

Study Completion

April 1, 2021

Last Updated

February 24, 2021

Record last verified: 2021-02

Locations